financetom
Business
financetom
/
Business
/
Hong Kong bourse logs first profit in three quarters, IPOs pick up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hong Kong bourse logs first profit in three quarters, IPOs pick up
Aug 21, 2024 12:49 AM

HONG KONG (Reuters) -Hong Kong's bourse has booked its first profit growth in three quarters, marking record revenue and income for an April-June period as IPO and trading activity improved.

Net income for Hong Kong Exchanges and Clearing (HKEX) climbed 9% from a year earlier to HK$3.16 billion ($405 million) on a 7% gain in revenue.

The bourse said it had benefited from increases in trading and clearing fees as volumes across the cash, derivatives and commodities markets grew.

HKEX has been beset with challenges over the past few years, from Beijing's regulatory crackdown on a broad range of industries to rising U.S.-Sino tensions and lacklustre growth for the Chinese economy - all of which has greatly contributed to widespread disaffection with Chinese assets.

Its stock price is down some 15% for the year to date and was 1.9% lower in Wednesday's afternoon session after the results as investors noted the strong second quarter came after a particularly weak one.

But new Chief Executive Bonnie Chan said sentiment appears to be on the mend.

"Looking ahead, while macro-environment uncertainties persist, we remain cautiously optimistic about the outlook for the rest of the year," she said in a statement.

IPO activity which had been hit hard during the first quarter when Chinese stocks suffered a sharp sell-off is now showing "signs of warming", said Chan, who took the helm in March.

This was also helped by efforts by mainland Chinese authorities to expedite approvals of IPOs though deal values have been relatively small, all under $500 million.

Eighteen firms went public in Hong Kong during the second quarter compared to 12 in the first quarter, raising about 80% more in funds.

But some IPO initiatives have yet to get firmly off the ground. A plan to facilitate more specialist technology companies to make their debuts has attracted just two firms since new rules were introduced a year ago.

The exchange has also been making efforts to boost the attractiveness of its derivative offerings, announcing in April a major investment to develop its in-house derivatives platform.

($1 = 7.7906 Hong Kong dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
LZ Technology Says Principal Shareholders Extend Lock-Up to August 2026
LZ Technology Says Principal Shareholders Extend Lock-Up to August 2026
Aug 13, 2025
09:03 AM EDT, 08/13/2025 (MT Newswires) -- LZ Technology ( LZMH ) said Wednesday all of its principal shareholders have agreed to extend their lock-up restrictions until Aug. 31, 2026, from the original 180-day period following the company's February initial public offering. The extension covers holders of about 100% of the company's Class A shares and 96.19% of Class B...
ImmunityBio Says CD19 CAR-NK Early Phase Trial Shows Complete Responses in Non-Hodgkin Lymphoma Patients
ImmunityBio Says CD19 CAR-NK Early Phase Trial Shows Complete Responses in Non-Hodgkin Lymphoma Patients
Aug 13, 2025
09:16 AM EDT, 08/13/2025 (MT Newswires) -- ImmunityBio ( IBRX ) said Wednesday that early findings from a phase I trial using its CD19 CAR-NK natural killer cell therapy showed complete responses in the first patients treated so far with late-stage Waldenstrom macroglobulinemia, a type of non-Hodgkins lymphoma. The study is a first-in-human trial assessing the safety and preliminary efficacy...
Trump Gives Canadian Tourism a Boost, Notes Rosenberg Research
Trump Gives Canadian Tourism a Boost, Notes Rosenberg Research
Aug 13, 2025
09:20 AM EDT, 08/13/2025 (MT Newswires) -- Canadians believe that they are being unfairly hurt by the United Sttaes trade actions, when in fact, that isn't really the case, said Rosenberg Research. However, this perception has unleashed a wild move on the part of Canadian consumers to buy local and travel domestically, noted Rosenberg Research. So, in some perverse sense,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved